Very early researchUnknownNCT02691169What this trial is testingIntegrated 18F-labelled PSMA ProjectWho this might be right forProstate Cancer St. Joseph's Healthcare Hamilton 10
Not applicableEnded earlyNCT05742269What this trial is testingMolecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast CancerWho this might be right forMetastatic Triple-Negative Breast Carcinoma Karolinska University Hospital 3
Not applicableEnded earlyNCT02149173What this trial is testingF-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyWho this might be right forEstrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7 University of Washington 29
Very early researchUnknownNCT02817945What this trial is testingDual SSTR2 and Integrin αvβ3 Targeting PET/CT ImagingWho this might be right forLung CancerNeuroendocrine Neoplasm Peking Union Medical College Hospital 100
Early research (Phase 1)Not Yet RecruitingNCT07660939What this trial is testingGPRC5D Targeted PET/CT Imaging in Plasma Cell DisordersWho this might be right forPlasma Cell DisordersMultiple Myeloma (MM) Peking University First Hospital 50
Testing effectiveness (Phase 2)UnknownNCT03116945What this trial is testingNovel Gallium Imaging in Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Rutgers, The State University of New Jersey 18
Early research (Phase 1)Looking for participantsNCT06062745What this trial is testingPilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CTWho this might be right forAdvanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04318561What this trial is testingGallium-68 Labeled LM3 PET/CT in Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumors Peking Union Medical College Hospital 40
Large-scale testing (Phase 3)Study completedNCT03739684What this trial is testingStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate CancerWho this might be right forProstate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more Progenics Pharmaceuticals, Inc. 208
Testing effectiveness (Phase 2)Ended earlyNCT02811744What this trial is testing11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced NeuroinflammationWho this might be right forMild Cognitive Impairment University of Pennsylvania 11
Not applicableLooking for participantsNCT07782944What this trial is testingCD38 Targeted -PET/ CT for Multiple MyelomaWho this might be right forMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma Guilin Medical University, China 100
Not applicableNot Yet RecruitingNCT07370805What this trial is testing18F-FAPI PET in Lung CancerWho this might be right forLung Cancer (Diagnosis) First Affiliated Hospital of Zhejiang University 120
Testing effectiveness (Phase 2)Looking for participantsNCT07325253What this trial is testingA Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease ManifestationsWho this might be right forPilot StudyPET/CT ImagingHost Disease Manifestation M.D. Anderson Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT01930812What this trial is testing18F-NaF PET Imaging for Bone ScintigraphyWho this might be right forBone Metastases From Breast or Prostate Cancer British Columbia Cancer Agency 286
Early research (Phase 1)Study completedNCT00961831What this trial is testingRadiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and PatientsWho this might be right forNeoplasm Bayer 20
Not applicableEnded earlyNCT04060745What this trial is testingGlucose Metabolism in Brown Adipose Tissue (BAT) in Young Healthy Men Evaluated by Deuterium Metabolic Imaging (DMI)Who this might be right forType2 DiabetesObesityMetabolic Syndrome University of Aarhus 10
Not applicableEnded earlyNCT07441330What this trial is testingEvaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast CancerWho this might be right forBreast Cancer GCS Ramsay Santé pour l'Enseignement et la Recherche 42
Not applicableEnrolling By InvitationNCT07319130What this trial is testingClinical Study of 68Ga-labeled Novel Nectin-4 Bicyclic Peptide PET/CT for Imaging of Solid Tumors With High Nectin-4 ExpressionWho this might be right forSolid Tumors With High Expression of Nectin4 The First Affiliated Hospital of Soochow University 10
Large-scale testing (Phase 3)Study completedNCT04552847What this trial is testingAl18F-NOTA-octreotide PET Imaging in Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumors Universitaire Ziekenhuizen KU Leuven 85
Very early researchNot Yet RecruitingNCT07168785What this trial is testing[18F]-AraG PET Imaging in LA HNSCCWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC)Locally Advanced Head and Neck Squamous Cell Carcinoma Indiana University 5